BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

833 related articles for article (PubMed ID: 26175036)

  • 1. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.
    Kanokrungsee S; Chanprapaph K; Chaiyabutr C; Vachiramon V
    Lasers Med Sci; 2016 Sep; 31(7):1343-9. PubMed ID: 27291387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional CO
    Yuan J; Chen H; Yan R; Cui S; Li YH; Wu Y; Gao XH; Chen HD
    Eur J Dermatol; 2016 Dec; 26(6):592-598. PubMed ID: 27818365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S; Khunkhet S; Rojhirunsakool S; Thadvibun K; Sahaspot T
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of fractional carbon dioxide laser with narrow band ultraviolet B to induce repigmentation in stable vitiligo: A comparative study.
    Doghaim NN; Gheida SF; El-Tatawy RA; Mohammed Ali DA
    J Cosmet Dermatol; 2019 Feb; 18(1):142-149. PubMed ID: 29707867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
    Eşme P; Gür Aksoy G; Elçin G
    Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of using fractional CO
    Ghasemloo S; Gauthier Y; Ghalamkarpour F
    J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of fractional carbon dioxide laser combined with narrow-band ultraviolet B phototherapy for non-segmental vitiligo: a systematic review and meta-analysis.
    Kim WI; Kim S; Lee SH; Cho MK
    Lasers Med Sci; 2021 Feb; 36(1):165-173. PubMed ID: 32572662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
    Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
    Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combination of fractional CO
    El-Zawahry MB; Zaki NS; Wissa MY; Saleh MA
    Lasers Med Sci; 2017 Dec; 32(9):1953-1958. PubMed ID: 28748302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablative fractional Co
    Liu L; Wu Y; Zhang J; Gu H; Luan Q; Qian L; Wang Y; Gao L; Wang H; Xiao B; Sun Y; Li H; Chen K; Zeng F; Li C; Gao T; Gao XH
    J Dermatolog Treat; 2019 Jun; 30(4):320-327. PubMed ID: 30081694
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial UVB phototherapy preceding a fractional CO
    Helou J; Soutou B; Maatouk I; Merhy R; Assaf J; Sarkis AS; Jabbour R; Kaikati J; Tomb R
    J Cosmet Dermatol; 2022 Dec; 21(12):6783-6787. PubMed ID: 36121343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study on the use of fractional CO
    Bakr RM; Abdel-Gaber RM; Tawfik YM
    Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.
    Li L; Wu Y; Li L; Sun Y; Qiu L; Gao XH; Chen HD
    Dermatol Ther; 2015; 28(3):131-4. PubMed ID: 25753514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.